Jul 15, 2021 7:30am EDT Sigyn Therapeutics Announces Rapid Elimination of Hepatic Toxins from Human Blood Plasma
Jul 13, 2021 9:31am EDT Sigyn Therapeutics Reports Preliminary Results of Hepatic Encephalopathy Toxin Study
Jun 28, 2021 9:30am EDT The Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19
Mar 08, 2021 3:08pm EST Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 04, 2021 8:10am EST Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
Jan 12, 2021 8:30am EST Sigyn Therapeutics (SIGY) CEO Note: Overcoming the Limitations of Previous Cytokine Storm Treatment Strategies
Jan 06, 2021 8:30am EST Sigyn Therapeutics™ Reports Results of Pilot Study to Address Inflammatory CytoVesicles
Dec 01, 2020 8:45am EST Sigyn Therapeutics™ Reports Simultaneous Clearance of Endotoxin and Inflammatory Cytokines From Human Blood Plasma
